RAI14 and neoplasm: It has been documented [52] that a knockdown of the RAI14 gene can raise the sensitivity of tumor cells to drugs such as epi-amycin and cisplatin, and patients with high RAI14 expression are at higher risk of developing resistance to chemotherapeutic drugs (paclitaxel, epi-amycin, docetaxel, etc.).